Therapy-related preleukemic syndrome
Journal Article
·
· Cancer (Philadelphia); (United States)
DOI:https://doi.org/10.1002/1097-0142(19810401)47:7<1867::AID-CNCR2820470725>3.0.CO;2-S·
OSTI ID:5585110
Eight patients developed the preleukemic syndrome after having been exposed to cytotoxic drugs for other primary diseases. All eight subsequently developed acute nonlymphocytic leukemia (ANLL). Survival following the onset of the preleukemic syndrome ranged from 5-34 months with a median of 11 months. Once overt leukemia developed median survival was three months. No patient responded to conventional antileukemic therapy. A higher incidence of chromosomal abnormalities was noted in bone marrow cells of this group (five of six) when compared with a larger group of preleukemic patients not known to have been exposed to mutagens (four of 21). In addition, two patients had second chromosome studies after overt leukemia developed and there was no evidence of cytogenetic clonal evolution. The clinical course and cytogenetic data in these patients attest to the relevance of our criteria in identifying the preleukemic syndrome and suggest that the leukemic clone was fully established during the preleukemic phase. Thus, patients previously exposed to cytotoxic therapy who develop the preleukemic syndrome may be viewed as having early leukemia.
- OSTI ID:
- 5585110
- Journal Information:
- Cancer (Philadelphia); (United States), Journal Name: Cancer (Philadelphia); (United States) Vol. 47:7; ISSN CANCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases
Chromosome abnormalities in Down's syndrome patients with acute leukemia
Translocations (5; 17) and (7; 17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Hut anomaly and small vacuolated granulocytes
Journal Article
·
Sat Jun 01 00:00:00 EDT 1985
· Blood; (United States)
·
OSTI ID:5021579
Chromosome abnormalities in Down's syndrome patients with acute leukemia
Journal Article
·
Tue Sep 01 00:00:00 EDT 1981
· Blood; (United States)
·
OSTI ID:5964019
Translocations (5; 17) and (7; 17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Hut anomaly and small vacuolated granulocytes
Journal Article
·
Fri Jun 01 00:00:00 EDT 1990
· Cancer Genetics and Cytogenetics; (USA)
·
OSTI ID:6743369
Related Subjects
550400 -- Genetics
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
560151 -- Radiation Effects on Animals-- Man
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMAL CELLS
ANIMAL TISSUES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BONE MARROW
BONE MARROW CELLS
CHROMOSOMAL ABERRATIONS
COMPARATIVE EVALUATIONS
CONNECTIVE TISSUE CELLS
DISEASES
GENETIC EFFECTS
GENETIC RADIATION EFFECTS
HEMATOPOIETIC SYSTEM
HEMIC DISEASES
LEUKEMIA
MEDICINE
MUTAGENS
MUTATIONS
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATIENTS
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SOMATIC CELLS
THERAPY
TISSUES
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
560151 -- Radiation Effects on Animals-- Man
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMAL CELLS
ANIMAL TISSUES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BONE MARROW
BONE MARROW CELLS
CHROMOSOMAL ABERRATIONS
COMPARATIVE EVALUATIONS
CONNECTIVE TISSUE CELLS
DISEASES
GENETIC EFFECTS
GENETIC RADIATION EFFECTS
HEMATOPOIETIC SYSTEM
HEMIC DISEASES
LEUKEMIA
MEDICINE
MUTAGENS
MUTATIONS
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATIENTS
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SOMATIC CELLS
THERAPY
TISSUES